Susan Johnson

Academic Program Professional 2, Rad/Pediatric Radiology

Current Role at Stanford

Program Manager at the Stanford Center for Interventional Radiology Innovation (IRIS)

Education & Certifications

Bachelor of Biomedical Science, Deakin University (2003)
Bachelor of Science (Honors), University of Melbourne, Medical Biology (2004)
PhD, University of Melbourne, Immunology (2008)

All Publications

Profiles With Related Publications

close
Jeffrey Bunker

Fellow in Medicine - Med/Infectious Diseases
Clinical Focus
Infectious Diseases, Internal Medicine, Fellow

12 Total Publications
close
Cornelia L. Dekker, M.D.

Professor (Research) of Pediatrics (Infectious Diseases), Emerita
Research Interests
The Stanford-LPCH Vaccine Program provides an infrastructure for conducting clinical studies of vaccines in children and adults. We conduct immunology studies of seasonal influenza vaccines in twins, in a longitudinal cohort of young and elderly adults and studies of various vaccine candidates for NIH and industry. Additionally, we were a CDC Clinical Immunization Safety Assessment site for 10 years working on safety issues concerning licensed vaccines.

140 Total Publications
close
Kevin Brian Einkauf

MD Student with Scholarly Concentration in Clinical Research, expected graduation Spring 2026

18 Total Publications
close
Edgar Engleman

Professor of Pathology and of Medicine (Immunology and Rheumatology)
Research Interests
Dendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.

291 Total Publications
close
C. Garrison Fathman

Professor of Medicine (Immunology and Rheumatology), Emeritus
Research Interests
My lab of molecular and cellular immunology is interested in research in the general field of T cell activation and autoimmunity. We have identified and characterized a gene (GRAIL) that seems to control regulatory T cell (Treg) responsiveness by inhibiting the Treg IL-2 receptor desensitization. We have characterized a gene (Deaf1) that plays a major role in peripheral tolerance in T1D. Using PBC gene expression, we have provisionally identified a signature of risk and progression in T1D.

329 Total Publications
close
Irina Gurevich

Basic Life Research Scientist, Dermatology

15 Total Publications
close
James Kahn

Professor of Medicine (General Medical Disciplines), Emeritus
Research Interests
My initial research activities involved antiretroviral and novel therapeutic treatments of HIV infection, understanding elements of HIV pathogenesis associated with acute HIV infection and post exposure prevention. My most recent scholarly activities concentrate on working as a team to capitalize on the data stored in electronic medical records, HIV disease modeling and using electronic medical records for outcome research and developing a mentorship program for early career scientists.

144 Total Publications
close
Dale Daniel Kim

MD Student with Scholarly Concentration in Clinical Research / Health Equity and Social Justice, expected graduation Spring 2028

11 Total Publications
close
Wilson F Kuswanto, MD, PhD

Adjunct Clinical Assistant Professor, Medicine - Immunology & Rheumatology
Clinical Focus
Tissue inflammation, Rheumatology, Osteoarthritis, Rheumatoid Arthritis, Sjögren's syndrome, Sarcoidosis, Internal Medicine

12 Total Publications
close
Sooyeon Lee

Instructor, Medicine - Endocrinology, Gerontology, & Metabolism

17 Total Publications
close
David B. Lewis

Naddisy Foundation Professor of Pediatric Food Allergy, Immunology, and Asthma
Clinical Focus
Primary Immunodeficiency, Pediatrics
Research Interests
My laboratory is focused on defining cellular and molecular mechanisms that limit T cell responses to vaccines and pathogens during normal early postnatal development and in cases of inherited genetic immunodeficiencies. We are also determinomg how these limitations in immunity can be overcome by using novel approaches for vaccine adjuvants for influenza vaccine and by using catalytically inactive Cas proteins for inducing endogenous gene expression.

179 Total Publications
close
Crystal Mackall

Ernest and Amelia Gallo Family Professor and Professor of Pediatrics and of Medicine
Research Interests
Recent clinical studies, by us and others, have demonstrated that genetically engineered T cells can eradicate cancers resistant to all other therapies. We are identifying new targets for these therapeutics, exploring pathways of resistance to current cell therapies and creating next generation platforms to overcome therapeutic resistance. We have discovered novel insights into the biology of human T cell exhaustion and developed approaches to prevent and reverse this phenomenon.

421 Total Publications